Synovics Pharmaceuticals, Inc. (OTCPK: SYVC)
Health Care · Pharmaceuticals · US
$—
— today · — 1Y
Synovics Pharmaceuticals, Inc. (OTCPK: SYVC) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $3.65K and employs 155 people.
trading between 0.00 and 0.00.
Tweenvest scores Synovics Pharmaceuticals, Inc. across four factors: value 50/100. Its strongest factor is value.
SYVC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.65K
- Revenue (TTM)
- $19.09M
- P/E
- —
- EPS
- -0.18
- Dividend yield
- —
- Beta (5Y)
- 70.77
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 36.49M
- Employees
- 155
- Next earnings
- —
About Synovics Pharmaceuticals, Inc.
Synovics Pharmaceuticals, Inc., through its subsidiaries, engages in the development, manufacture, and commercialization of generic over-the-counter (OTC) pharmaceutical products and generic prescription drug products primarily in the United States. The company’s OTC product categories include analgesics, cough, cold, antihistamines, asthma relief, and laxatives. It packages and distributes its products to chain drug stores, wholesalers, and distributors in the United States. The company was formerly known as Bionutrics Inc. and changed its name to Synovics Pharmaceuticals, Inc. in 2006. Synovics Pharmaceuticals, Inc. was founded in 1983 and is based in Fort Lauderdale, Florida. Synovics Pharmaceuticals, Inc. operates as a subsidiary of Maneesh Pharmaceuticals Limited.
- ISIN
- US87163M1018
- Founded
- 1983
- Listed since
- Mar 29, 2004
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.